Ignite Creation Date:
2025-12-24 @ 4:49 PM
Ignite Modification Date:
2026-01-02 @ 2:29 AM
Study NCT ID:
NCT03589950
Status:
UNKNOWN
Last Update Posted:
2018-07-18
First Post:
2018-06-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung Cancer
Sponsor:
The First People's Hospital of Lianyungang
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Anlo01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |